Susquehanna International Group, LLP Repare Therapeutics Inc. Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$3.02 - $4.7 $90,373 - $140,647	29,925 Added 203.75%	44,612 $147,000
Q1 2024 May 07, 2024	SELL	$4.53 - $8.41 $55,963 - $103,897	-12,354 Reduced 45.69%	14,687 $69,000
Q4 2023 Feb 14, 2024	SELL	$3.22 - $11.79 $64,548 - $236,342	-20,046 Reduced 42.57%	27,041 $197,000
Q3 2023 Nov 14, 2023	BUY	$8.16 - $13.01 $384,229 - $612,601	47,087 New	47,087 $568,000
Q1 2023 May 16, 2023	SELL	$9.32 - $15.06 $69,704 - $112,633	-7,479 Reduced 24.77%	22,710 $223,000
Q4 2022 Feb 14, 2023	BUY	$12.5 - $18.13 $377,362 - $547,326	30,189 New	30,189 $444,000
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $373,127 - $533,499	18,979 New	18,979 $400,000
Q1 2021 May 17, 2021	SELL	$25.89 - $44.46 $163,184 - $280,231	-6,303 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.42 - $39.5 $147,616 - $248,968	6,303 New	6,303 $216,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $56.6M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.